[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 42, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mallory  Morales CPA", "age": 41, "title": "Principal Financial & Accounting Officer, Chief Accounting Officer and Treasurer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Paula  George CPA", "title": "Director of Accounting & Operations and Assistant Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 52, "title": "Chief People Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.6, "open": 5.62, "dayLow": 5.47, "dayHigh": 5.76, "regularMarketPreviousClose": 5.6, "regularMarketOpen": 5.62, "regularMarketDayLow": 5.47, "regularMarketDayHigh": 5.76, "payoutRatio": 0.0, "beta": 0.37, "forwardPE": -3.5060976, "volume": 375631, "regularMarketVolume": 375631, "averageVolume": 1438682, "averageVolume10days": 1388360, "averageDailyVolume10Day": 1388360, "bid": 5.61, "ask": 5.79, "bidSize": 8, "askSize": 8, "marketCap": 245226000, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 6.18, "fiftyDayAverage": 3.8828, "twoHundredDayAverage": 2.295575, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 186478608, "profitMargins": 0.0, "floatShares": 27538425, "sharesOutstanding": 42648000, "sharesShort": 1581442, "sharesShortPriorMonth": 1654759, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0435, "heldPercentInsiders": 0.24124001, "heldPercentInstitutions": 0.10574, "shortRatio": 3.83, "shortPercentOfFloat": 0.056900002, "impliedSharesOutstanding": 42648000, "bookValue": 0.804, "priceToBook": 7.151741, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -62128864, "trailingEps": -1.9, "forwardEps": -1.64, "enterpriseToEbitda": -2.927, "52WeekChange": 3.7520661, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 5.75, "targetHighPrice": 21.0, "targetLowPrice": 8.0, "targetMeanPrice": 12.8, "targetMedianPrice": 12.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 26355498, "totalCashPerShare": 0.726, "ebitda": -63700328, "totalDebt": 4000560, "quickRatio": 3.52, "currentRatio": 3.703, "debtToEquity": 13.826, "returnOnAssets": -0.68372, "returnOnEquity": -1.3046601, "freeCashflow": -29878488, "operatingCashflow": -51509300, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "regularMarketChangePercent": 2.67857, "regularMarketPrice": 5.75, "corporateActions": [], "marketState": "CLOSED", "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketTime": 1756511936, "regularMarketTime": 1756497601, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "postMarketChangePercent": -1.38956, "postMarketPrice": 5.6701, "postMarketChange": -0.0798998, "regularMarketChange": 0.15, "regularMarketDayRange": "5.47 - 5.76", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1438682, "fiftyTwoWeekLowChange": 4.65, "fiftyTwoWeekLowChangePercent": 4.2272725, "fiftyTwoWeekRange": "1.1 - 6.18", "fiftyTwoWeekHighChange": -0.42999983, "fiftyTwoWeekHighChangePercent": -0.06957926, "fiftyTwoWeekChangePercent": 375.2066, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.9, "epsForward": -1.64, "epsCurrentYear": -1.65, "priceEpsCurrentYear": -3.4848485, "fiftyDayAverageChange": 1.8671999, "fiftyDayAverageChangePercent": 0.48089004, "twoHundredDayAverageChange": 3.454425, "twoHundredDayAverageChangePercent": 1.5048192, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]